Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Gynecologic 1 Gastrointestinal 1

Conditions

Ovarian Carcinosarcoma 1

Interventions

Paclitaxel 77 pembrolizumab 65 Carboplatin 57 Bevacizumab 57 Specimen Handling 49 Magnetic Resonance Spectroscopy 40 Cisplatin 35 olaparib 31 Gemcitabine 27 liposomal doxorubicin 25 Biopsy 22 Taxes 19 Cyclophosphamide 18 Topotecan 17 Nivolumab 17 Doxorubicin 16 Immunoglobulin G 15 niraparib 14 Letrozole 14 Disulfides 14 lenvatinib 13 fludarabine 13 Surveys and Questionnaires 12 Drug Therapy 12 Radiotherapy 11 Platinum 11 atezolizumab 10 abemaciclib 10 durvalumab 9 Fulvestrant 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Antineoplastic Agents × Gynecologic × 90 days × Clear all

NCT03651206 2026-06-01

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡